February 06,2008
Sen. Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA
Please view the printer-friendly version of Senator Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA.
Next Article Previous Article
Recent News
- Crapo: Bessent Exceptionally Qualified to be Treasury Secretary
- Crapo Statement at Treasury Secretary Nomination Hearing
- Crapo, Wyden, Bipartisan Senators Call on President Biden to Stop Rushing Trade Negotiations Behind Closed Doors
- Crapo Announces Finance Committee Staff for the 119th Congress
- Crapo Announces Treasury Secretary Nomination Hearing